Delpor
Founded 2009 · 5 employees on LinkedIn · 2 known investors
Delpor develops subcutaneous implant devices that deliver therapeutic drugs over extended periods (6-12 months) for chronic condition treatment. The company's passive implant technology enables sustained-release drug delivery through simple in-office procedures, targeting improved patient adherence and consistent pharmacokinetic profiles.
Investors · 2
Non-dilutive funding · 8 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $2.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $224.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $224.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $222.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2013 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $344.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Delpor do?
- Delpor develops subcutaneous implant devices that deliver therapeutic drugs over extended periods (6-12 months) for chronic condition treatment. The company's passive implant technology enables sustained-release drug delivery through simple in-office procedures, targeting improved patient adherence and consistent pharmacokinetic profiles.
- Who are Delpor's investors?
- Delpor's investors include Kairos Venture Investments, Llc, Ulu Ventures.